A note from Patrick J. Cozzone, MAGMA Editor-in-Chief.

MAGMA

Singapore Bioimaging Consortium, 11 Biopolis Way, #02-02 Helios, Singapore, 138667, Singapore.

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10334-017-0662-8DOI Listing

Publication Analysis

Top Keywords

note patrick
4
patrick cozzone
4
cozzone magma
4
magma editor-in-chief
4
note
1
cozzone
1
magma
1
editor-in-chief
1

Similar Publications

Article Synopsis
  • The AAOS guidelines indicate that early and delayed rehabilitation after arthroscopic rotator cuff repairs have similar healing outcomes, supported by "strong" evidence.
  • A study analyzed randomized controlled trials (RCTs) with non-significant tendon re-tear rates to calculate the reverse fragility index (RFI) and reverse fragility quotient (RFQ), revealing that these studies are statistically weak.
  • The findings suggest that the evidence supporting the equivalency of both rehabilitation strategies is fragile, as small changes in patient outcomes can significantly affect results; thus, RFI should be routinely reported in clinical guidelines.
View Article and Find Full Text PDF
Article Synopsis
  • Mycosis fungoides (MF), a type of skin cancer, is often misdiagnosed early on because it resembles conditions like atopic dermatitis (AD), complicating the distinction from parapsoriasis, which can appear in small or large plaques.
  • The study used single-cell RNA sequencing to analyze skin samples from patients showing both parapsoriasis and early-stage MF to better understand these diseases.
  • Results showed that large-plaque lesions tended to have signs of early-stage MF while small-plaque lesions were more diverse and lacked cancerous characteristics, leading researchers to propose the term "polyclonal parapsoriasis en plaque" for these unique lesions.
View Article and Find Full Text PDF

Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists.

Mol Pharmacol

April 2024

Drug Discovery Biology Theme (P.K., G.C., C.A.H., D.W., P.M.S.) and ARC Centre for Cryo-Electron Microscopy of Membrane Proteins (P.K., D.W., P.M.S.), Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia; and Research & Early Development, Novo Nordisk, Novo Nordisk Park, Maaloev, Denmark (T.G., B.B.-G.)

Dual amylin and calcitonin receptor agonists (DACRAs) show promise as efficacious therapeutics for treatment of metabolic disease, including obesity. However, differences in efficacy in vivo have been observed for individual DACRAs, indicating that detailed understanding of the pharmacology of these agents across target receptors is required for rational drug development. To date, such understanding has been hampered by lack of direct, subtype-selective, functional assays for the amylin receptors (AMYRs).

View Article and Find Full Text PDF

Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process. As such, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) critically affect hepatic regeneration in rodent models. The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!